Yuanbao Q2 Revenue Surges 30% to 1.39 Billion RMB

Yuanbao (NASDAQ: YB) reported second-quarter 2026 revenue of RMB 1.39 billion, a 30.1% increase from the prior year period. The growth was primarily driven by expansion in insurance distribution and system services, which collectively lifted net income by 35.6% to RMB 413.2 million. According to the earnings report covered by GN markets/earnings (en-US), the company achieved a net income margin of 29.7%, while non-GAAP adjusted net income rose 32.6% to RMB 431.2 million.

CFO Huirui Wan attributed the financial performance to the durability of the company’s growth model and disciplined scaling. The balance sheet strengthened significantly, with cash and cash equivalents, time deposits, restricted cash, and short-term investments totaling RMB 5.16 billion at the end of June. This represents a 50.9% year-over-year increase and an 8.8% rise from the end of the first quarter, providing a robust liquidity buffer for continued operational expansion.

Distribution and System Services Drive Growth

Insurance distribution services revenue climbed 30.4% to RMB 457.4 million, supported by increased policy purchases through the platform and enhanced targeted marketing efforts. System services revenue, the largest contributor to the top line, rose 22.8% to RMB 881.9 million. Management cited improvements in the consumer service-cycle engine, which strengthened marketing, analytics, and customer-related services for insurance carrier partners. The segment also benefited from expanded service offerings to both existing and new insurer clients.

Yuanbao introduced a new advertising services segment during the quarter, generating RMB 52.8 million in revenue. Management described this business as a small share of total quarterly revenue, providing insurance carriers with intelligent marketing and traffic-optimization solutions via the company’s proprietary platform. While this new line added revenue, it also contributed to a 139.1% surge in operations and support expenses, which reached RMB 97.8 million. Total operating costs and expenses increased 21.9% year over year to RMB 341.3 million, reflecting the investment in new capabilities and staff.

Health Insurance Products Expand Coverage

CEO Rui Fang highlighted the company’s continued collaboration with insurance carriers to expand access to commercial health insurance, particularly for consumers with pre-existing conditions and rare diseases. In June, Yuanbao upgraded its Super Medical Insurance series, adding access to special-needs medical resources at public hospitals and broadening coverage for advanced drugs and devices. The updated products also introduced inpatient rehabilitation coverage for specific conditions, maintaining an affordable-pricing approach while expanding benefits.

In May, the company partnered with insurers to launch the Complete Guardian Million-RMB Medical Insurance, a product that does not require health disclosures and covers general pre-existing conditions within policy limits. A no-health-disclosure version of the Guardian Insurance million-RMB critical illness product was also introduced. These moves align with broader policy support for commercial health insurance, allowing Yuanbao to capture a wider consumer base without compromising underwriting risk parameters.

AI Infrastructure Supports Operational Efficiency

Yuanbao continued to expand its artificial intelligence infrastructure to support its claims and customer assistance processes. As of the end of the second quarter, the company’s model matrix included more than 5,100 models capable of analyzing over 5,900 labels. This technological investment supports the company’s R&D spending, which increased 21.7% to RMB 99.5 million as the firm added technical staff. The integration of AI into core operations aims to maintain cost discipline while scaling service capacity for insurance partners.